Pharmacy Technician’s Letter | CE Made Simple & License Tracking

February 2026 Issue

Be Ready to Dispense New ORAL Semaglutide for Weight Loss

Patients are asking about Rx semaglutide tablets (Wegovy), the first ORAL GLP-1 agonist FDA-approved for obesity and overweight...

Resources

Chart: GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart
Chart: Comparison of Weight Loss Products

Listen for Questions About Childhood Immunizations

Changes to the CDC childhood vaccine schedule are causing confusion...

Know How Meds for Fibromyalgia Stack Up

New sublingual (SL) cyclobenzaprine (Tonmya) will raise questions about how meds for fibromyalgia compare...

Prevent Mix-Ups With COPD Meds

New COPD treatment guidelines will put an even greater focus on preventing med mishaps...

GO TO FULL ISSUE

CE & Training

FEATURED SELF-STUDY CE: Communicating With Empathy

CE-IN-THE-LETTER: Pharmacy Technician's Letter February 2026

LIVE CE: Pharmacy Essential Updates February 2026

PODCAST CE: Clinical Capsules - Preventing Respiratory Syncytial Virus (RSV): Immunization Updates

GO TO CE & TRAINING ORGANIZER >

Featured Clinical Resources

GLP-1 and GIP/GLP-1 Receptor Agonists interactive chart

Quantity & Days' Supply Calculations: unlimited math quizzes!

Group Purchases & Pricing

Pharmacy Technician’s Letter is eligible for bulk discounts. Ensure staff meet license renewal requirements. Easily manage training. Bundle with other products for significant savings. Request information